Creative Biolabs is a biotechnology company that specializes in custom biotechnology and pharmaceutical services, focusing on antibody discovery and engineering. The company has positioned itself as a trusted provider of cost-effective outsourcing solutions for clients in the biotechnology and pharmaceutical sector, as well as government and academic research laboratories globally. Founded by scientists dedicated to conquering cancer, the company's business model prioritizes custom services to optimize the drug development process. With a diverse team and a commitment to delivering high-quality results efficiently, Creative Biolabs offers services such as protein production, hybridoma, immunoassay, tissue array, antibody engineering, and other biotechnology-related services. As of now, the company does not have information available about its headquarters, last investment, or last investment investors. With expertise in biotechnology, health care, and robotics, Creative Biolabs presents a compelling proposition in the rapidly evolving biotech and pharmaceutical industries. [Check out their current job openings here](https://www.creative-biolabs.com/career/available-positions.aspx).
There is no investment information
No recent news or press coverage available for Creative Biolabs.